arrow
Back
A

Axel S. Merseburger

university of kiel

63H-index
849Paper Count
2.4WCitation Count
Published Papers 197
Publication Date
Corrigendum to “Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis” [Eur. Urol. Oncol. 8(5) (2025) 1340–1349]
err2025-12-30
err0
errOAAI
errRossella Nicoletti; Alex Qinyang Liu; Susan Evans-Axelsson; Asieh Golozar; Katharina Beyer; Bertrand De Meulder; Riccardo Campi; Mauro Gacci; Jeremy Yuen-Chun Teoh; Carl Steinbesser; Ayman Hijazy; Artem Harbachou; James T. Brash; Peter-Paul M. Willemse; Teemu Murtola; Monique J. Roobol; Jesus Moreno Sierra; Anders Bjartell; Axel S. Merseburger; Pawel Rajwa
errShare
errSave
Stones and DNA damage - current perspectives in urology
err2025-12-01
err0
PREAI
errBorkowetz, Angelika; Merseburger, Axel S.
errShare
errSave
Influence of MRI fusion biopsy on treatment recommendations How reliable are biopsy results?
err2025-12-01
err0
errOAAI
errSchildhauer, P.; Muller, M.; Merseburger, A. S.; Weiler, S. M.; Furschke, A.; Elser, Y.; Moderegger, A.; Fender, H. E.
errShare
errSave
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
New Prostate Cancer Guideline: Is Biopsy of PI-RADS 3 Lesions Meaningful? The Role of Multiparametric MRI-Ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer
err2025-11-01
err0
PREAI
errSchildhauer, Paul; Muller, Marten; Merseburger, Axel S.; Furschke, Alexander; Elser, Yannic; Moderegger, Anton; Fender, Hendrik Eike
errShare
errSave
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis
err2025-10-08
err0
errOAAI
errRossella Nicoletti; Alex Qinyang Liu; Susan Evans-Axelsson; Asieh Golozar; Katharina Beyer; Bertrand De Meulder; Riccardo Campi; Mauro Gacci; Jeremy Yuen-Chun Teoh; Carl Steinbesser; Ayman Hijazy; Artem Harbachou; James T. Brash; Peter-Paul M. Willemse; Teemu Murtola; Monique J. Roobol; Jesus Moreno Sierra; Anders Bjartell; Axel S. Merseburger; Pawel Rajwa; Philip Cornford; Thomas Abbott; James Ndow; Juan Gomez Rivas; Eleanor Davies; Qi Feng; Robert Snijder
errShare
errSave
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
err2025-10-01
err0
errOAAI
errGrande, Enrique; Bellmunt, Joaquim; Hussain, Syed A.; Al Mansour, Mubarak M.; Bamias, Aristotle; Barthelemy, Philippe; Benjamin, David J.; Blais, Normand; Bourlon, Maria T.; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Felix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C.; Matsubara, Nobuaki; Merseburger, Axel S.; Mukherji, Deborah; Park, Chandler H.; Tran, Ben; da Trindade, Karine Martins; Urun, Yuksel; Kamat, Ashish M.; Birtle, Alison J.
errShare
errSave
CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply
err2025-09-29
err0
PREAI
errNeeraj Agarwal; Axel S Merseburger; Svetlana Andrianova; Arun A Azad
errShare
errSave
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITAN
err2025-09-29
err0
errOAAI
errAlejo Rodriguez-Vida; Angel Borque; Fernando Lopez-Campos; Alvaro Juarez Soto; Beatriz Garcillan; Cristian Vidal; Joana Lencart; Amitabha Bhaumik; Suneel D. Mundle; Suzy Van Sanden; Kim N. Chi; Anders Bjartell; Neeraj Agarwal; Axel S. Merseburger
errShare
errSave
errShare
errSave
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial
err2025-06-13
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; Nobuaki Matsubara; Stéphane Oudard; Fred Saad; Axel S Merseburger; Andrey Soares; Bradley A McGregor; Bogdan Zurawski; Marinos Tsiatas; Scott North; Igor Bondarenko; Margarita Alfie; Evangelos Bournakis; Lorenzo Antonuzzo; Lena Evilevitch; Andrew Simmons; Fong Wang; Roberta Ferraldeschi; Prachi Nandoskar; Sumanta K Pal
errShare
errSave
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer
err2025-06-03
err0
PREAI
errMike Wenzel; Thomas Steuber; Carolin Siech; Maximilian Kriegmair; Benedikt Hoeh; Derya Tilki; Axel S. Merseburger; Felix K.H. Chun; Philipp Mandel
errShare
errSave
DIAGNOSING PENILE FRACTURES: A RETROSPECTIVE COMPARISON OF MRI IMAGING AND ULTRASOUND
err2025-05-09
err0
PREAI
errMorische, S.; Gilbert, N.; Merseburger, A. S.; Brozat-Essen, S.
errShare
errSave
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis
err2025-05-01
err0
errOAAI
errTamás Fazekas; Marcin Miszczyk; Alexander Giesen; Tamás Kói; Fabio Zattoni; Lara Rodriguez-Sanchez; Takafumi Yanagisawa; Akihiro Matsukawa; Tibor Szarvas; Piotr Kryst; Juan Gómez Rivas; Axel S. Merseburger; Maria De Santis; Steven Joniau; Alberto Briganti; Giancarlo Marra; Péter Nyirády; Giorgio Gandaglia; Shahrokh F. Shariat; Pawel Rajwa
errShare
errSave
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis
err2025-05-01
err0
errOAAI
errMarcin Miszczyk; Tamás Fazekas; Paweł Rajwa; Akihiro Matsukawa; Ichiro Tsuboi; Michael S. Leapman; Gero Kramer; Maha Hussain; Axel Merseburger; Alberto Briganti; Anthony V. D’Amico; Silke Gillessen; Fred Saad; Shahrokh F. Shariat
errShare
errSave
Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study
err2025-04-01
err0
errOAAI
errMerseburger, Axel S.; Dornstauder, Eugen; Ohlmann, Carsten-Henning; Aprikian, Armen; Junker, Sophia; Hahn, Philipp; Chilelli, Andrew; Stoelzel, Matthias; Serikoff, Alexis; Spitzer, Stefan G.
errShare
errSave
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
err2025-02-01
err1
errOAAI
errRuiz-Vico, Maria; Wetterskog, Daniel; Orlando, Francesco; Thakali, Suparna; Wingate, Anna; Jayaram, Anuradha; Cremaschi, Paolo; Vainauskas, Osvaldas; Brighi, Nicole; Castellano-Gauna, Daniel; Astrom, Lennart; Matveev, Vsevolod B.; Bracarda, Sergio; Esen, Adil; Feyerabend, Susan; Senkus, Elzbieta; Piqueras, Marta Lopez-Brea; Gupta, Santosh; Wenstrup, Rick; Boysen, Gunther; Martins, Karla; Iwata, Kenneth; Chowdhury, Simon; Gourgioti, Georgia; Serikoff, Alexis; Gonzalez-Billalabeitia, Enrique; Merseburger, Axel S.; Demichelis, Francesca; Attard, Gerhardt
errShare
errSave
An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial
err2024-10-27
err2
errOAAI
errStruck, Julian Peter; Moharam, Nadim; Leitenberger, Armin; Weber, Joerg; Lusuardi, Lukas; Oswald, David; Rassweiler, Jens J.; Fiedler, Marcel; Hornak, Jakub; Babjuk, Marek; Micali, Salvatore; Zaraca, Carlo; Spreu, Thomas; Friedersdorff, Frank; Borgmann, Hendrik; Merseburger, Axel S.; Kramer, Mario W.
errShare
errSave